[go: up one dir, main page]

AU2001260847A1 - Compositions isolated from skin cells and methods for their use - Google Patents

Compositions isolated from skin cells and methods for their use

Info

Publication number
AU2001260847A1
AU2001260847A1 AU2001260847A AU6084701A AU2001260847A1 AU 2001260847 A1 AU2001260847 A1 AU 2001260847A1 AU 2001260847 A AU2001260847 A AU 2001260847A AU 6084701 A AU6084701 A AU 6084701A AU 2001260847 A1 AU2001260847 A1 AU 2001260847A1
Authority
AU
Australia
Prior art keywords
methods
skin cells
compositions isolated
isolated
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260847A
Inventor
Krishanand D. Kumble
James Greg Murison
Rene Onrust
Matthew Sleeman
Lorna Strachan
James D. Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genesis Research and Development Corp Ltd
Original Assignee
Genesis Research and Development Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Research and Development Corp Ltd filed Critical Genesis Research and Development Corp Ltd
Publication of AU2001260847A1 publication Critical patent/AU2001260847A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001260847A 2000-05-24 2001-05-24 Compositions isolated from skin cells and methods for their use Abandoned AU2001260847A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20665000P 2000-05-24 2000-05-24
US60206650 2000-05-24
US22123200P 2000-07-25 2000-07-25
US60221232 2000-07-25
PCT/NZ2001/000099 WO2001090357A1 (en) 2000-05-24 2001-05-24 Compositions isolated from skin cells and methods for their use

Publications (1)

Publication Number Publication Date
AU2001260847A1 true AU2001260847A1 (en) 2001-12-03

Family

ID=26901556

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260847A Abandoned AU2001260847A1 (en) 2000-05-24 2001-05-24 Compositions isolated from skin cells and methods for their use

Country Status (2)

Country Link
AU (1) AU2001260847A1 (en)
WO (1) WO2001090357A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2001055333A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
US20020146763A1 (en) * 2000-07-06 2002-10-10 Zeren Gao Murine cytokine receptor
US7402660B2 (en) 2000-08-02 2008-07-22 The Johns Hopkins University Endothelial cell expression patterns
AU2002225714A1 (en) * 2000-11-10 2002-05-21 The Regents Of The University Of California Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
US20020111302A1 (en) * 2000-11-30 2002-08-15 Y. Tom Tang Novel nucleic acids and polypeptides
US20060035237A1 (en) 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
US7081516B2 (en) 2002-08-26 2006-07-25 Case Western Reserve University Methods for categorizing patients
US7118912B2 (en) 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
US20030216315A1 (en) * 2002-02-13 2003-11-20 Duke University Modulation of immune response by non-peptide binding stress response polypeptides
AU2003236351A1 (en) * 2002-04-03 2003-10-27 Banyu Pharmaceutical Co., Ltd. Novel g protein-coupled receptor gene and protein bg8
WO2004001060A2 (en) 2002-06-20 2003-12-31 Bristol-Myers Squibb Company Identification and regulation of a g-protein coupled receptor, rai-3
EP1541677A4 (en) * 2002-07-10 2007-06-27 Takeda Pharmaceutical NEW PROTEINS AND THEIR USE
AU2003277583A1 (en) * 2002-11-06 2004-06-07 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Physiologically active polypeptide and its antibody and use thereof
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
WO2005063292A2 (en) * 2003-12-22 2005-07-14 Amgen Inc. Heh4 molecules and uses thereof
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
JP4903703B2 (en) 2004-06-10 2012-03-28 ザイモジェネティクス， インコーポレイテッド Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of use in inflammation
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
AU2007300393B2 (en) 2006-02-10 2012-05-31 Zymogenetics, Inc. Soluble IL-17RCx4 and methods of using in inflammation
AU2008296927C1 (en) 2007-09-06 2015-08-13 Case Western Reserve University Methods for diagnosing and treating cancers
EP2107068A1 (en) 2008-03-31 2009-10-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. MZB1, a novel B cell factor, and uses thereof
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
WO2013174404A1 (en) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
NZ746691A (en) 2012-11-13 2020-08-28 Astellas Pharma Inc Agents for treatment of claudin expressing cancer diseases
WO2014127785A1 (en) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2014146672A1 (en) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Therapy involving antibodies against claudin 18.2 for treatment of cancer
AU2019211121B2 (en) * 2018-01-26 2024-09-12 Cambridge Enterprise Limited Peptide exchange protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5850020A (en) * 1996-09-11 1998-12-15 Genesis Research & Development Corporation, Ltd. Materials and method for the modification of plant lignin content
DE19817557A1 (en) * 1998-04-09 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Human nucleic acid sequences from ovarian tumor tissue
US6573095B1 (en) * 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
CN1158386C (en) * 1998-04-29 2004-07-21 吉尼西斯研究及发展有限公司 Polynucleotides isolated from skin cells and methods of use thereof
EP1131350A4 (en) * 1998-11-19 2005-05-04 Millennium Pharm Inc Egf-like nucleic acids and polypeptides and uses thereof
GB9828840D0 (en) * 1998-12-30 1999-02-17 Univ Nottingham Trent Prostate cancer associated genes and their products
AU6745700A (en) * 1999-03-26 2000-11-02 Human Genome Sciences, Inc. 49 human secreted proteins
EP1173565A1 (en) * 1999-04-20 2002-01-23 ZymoGenetics, Inc. Adipocyte complement related protein homolog zacrp3
WO2000073448A1 (en) * 1999-05-27 2000-12-07 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp7
EP1514933A1 (en) * 1999-07-08 2005-03-16 Research Association for Biotechnology Secretory protein or membrane protein
EP1200587A2 (en) * 1999-07-21 2002-05-02 Incyte Genomics, Inc. Receptors and associated proteins
JP2003508030A (en) * 1999-08-11 2003-03-04 キュラジェン コーポレイション Novel polypeptide and nucleic acid encoding the same
GB9921785D0 (en) * 1999-09-16 1999-11-17 Univ Robert Gordon Apparatus and method

Also Published As

Publication number Publication date
WO2001090357A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
AUPQ419099A0 (en) Novel compositions and methods
AU2778801A (en) Antisense compositions and methods
AU2001282877A1 (en) Cosmetic compositions
AU3976200A (en) Cosmetic compositions
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2911100A (en) Skin cosmetic composition
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2001265919A1 (en) Cosmetic compositions
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001293728A1 (en) Cosmetic composition
AU2001238363A1 (en) Compositions for preventing cellulite in mammalian skin
AU2001245987A1 (en) Compositions and methods for gene therapy
AU5565099A (en) Pharmaceutical compositions and methods for use
AU2035300A (en) Initiator compositions and methods for their synthesis and use
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU5647601A (en) Hair treatment compositions
AU2001293074A1 (en) Human liver cell line
AU1152601A (en) Compositions and their use
AU2002216223A1 (en) Preservation of cells
AU2001232866A1 (en) Skin care compositions
AU2002201A (en) Cosmetic compositions and methods for lightening the skin
AU6094200A (en) Nor gene compositions and methods for use thereof
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001256202A1 (en) Cosmetic compositions